• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管平滑肌细胞在HIV环境中促成APOL1诱导的足细胞损伤。

Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu.

作者信息

Lan Xiqian, Wen Hongxiu, Saleem Moin A, Mikulak Joanna, Malhotra Ashwani, Skorecki Karl, Singhal Pravin C

机构信息

Renal Molecular Research Laboratory, Feinstein Institute for Medical Research, Department of Medicine, Hofstra North Shore LIJ Medical School, NY, USA.

Renal Academic Unit, Department of Pediatrics, University of Bristol, Bristol, UK.

出版信息

Exp Mol Pathol. 2015 Jun;98(3):491-501. doi: 10.1016/j.yexmp.2015.03.020. Epub 2015 Mar 18.

DOI:10.1016/j.yexmp.2015.03.020
PMID:25796344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4433601/
Abstract

Clinical reports have demonstrated that higher rates of non-diabetic glomerulosclerosis in African Americans can be attributed to two coding sequence variants (G1 and G2) in the APOL1 gene; however, the underlying mechanism is still unknown. Kidney biopsy data suggest enhanced expression of APOL1/APOL1 variants (Vs) in smooth muscle cells (SMCs) of renal vasculature. Since APOL1 is a secretory protein of relatively low molecular weight (41kDa), SMCs may be a contributory endocrine/paracrine source of APOL1 wild type (WT)/APOL1Vs in the glomerular capillary perfusate percolating podocytes. In the present study, we tested the hypothesis that an HIV milieu stimulated secretion of APOL1 and its risk variants by arterial SMCs contributes to podocyte injury. Human umbilical artery smooth muscle cells (HSMCs)-treated with conditioned media (CM) of HIV-infected peripheral mononuclear cells (PBMC/HIV-CM), CM of HIV-infected U939 cells, or recombinant IFN-γ displayed enhanced expression of APOL1. Podocytes co-cultured in trans-wells with HSMCs-over expressing APOL1WT showed induction of injury; however, podocytes co-cultured with HSMC-over expressing either APOL1G1 or APOL1G2 showed several folds greater injury when compared to HSMC-over expressing APOL1WT. Conditioned media collected from HSMC-over-expressing APOL1G1/APOL1G2 (HSMC/APOL1G1-CM or HSMC/APOL1G2-CM) also displayed higher percentages of injured podocytes in the form of swollen cells, leaky lysosomes, loss of viability, and enhanced sensitivity to adverse host factors when compared to HSMC/APOL1WT-CM. Notably, HSMC/APOL1WT-CM promoted podocyte injury only at a significantly higher concentrations compared to HSMC/APOL1G1/G2-CM. We conclude that HSMCs could serve as an endocrine/paracrine source of APOL1Vs, which mediate accelerated podocyte injury in HIV milieu.

摘要

临床报告表明,非裔美国人中较高的非糖尿病性肾小球硬化率可归因于载脂蛋白L1(APOL1)基因中的两个编码序列变异(G1和G2);然而,其潜在机制仍不清楚。肾活检数据表明,肾血管平滑肌细胞(SMC)中APOL1/APOL1变异体(Vs)的表达增强。由于APOL1是一种相对低分子量(41kDa)的分泌蛋白,因此SMC可能是肾小球毛细血管灌流足细胞中APOL1野生型(WT)/APOL1Vs的内分泌/旁分泌来源。在本研究中,我们测试了以下假设:HIV环境刺激动脉SMC分泌APOL1及其风险变异体,从而导致足细胞损伤。用人脐动脉平滑肌细胞(HSMC)分别处理HIV感染的外周单核细胞的条件培养基(PBMC/HIV-CM)、HIV感染的U939细胞的条件培养基或重组干扰素-γ,结果显示APOL1的表达增强。与过表达APOL1WT的HSMC在转孔中共培养的足细胞显示出损伤诱导;然而,与过表达APOL1G1或APOL1G2的HSMC共培养的足细胞相比过表达APOL1WT的HSMC,损伤程度高出数倍。与HSMC/APOL1WT-CM相比,从过表达APOL1G1/APOL1G2的HSMC(HSMC/APOL1G1-CM或HSMC/APOL1G2-CM)收集的条件培养基也显示出更高比例的足细胞损伤,表现为细胞肿胀、溶酶体渗漏、活力丧失以及对不良宿主因素的敏感性增强。值得注意的是,与HSMC/APOL1G1/G2-CM相比,HSMC/APOL1WT-CM仅在显著更高的浓度下才促进足细胞损伤。我们得出结论,HSMC可作为APOL1Vs的内分泌/旁分泌来源,在HIV环境中介导加速的足细胞损伤。

相似文献

1
Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu.血管平滑肌细胞在HIV环境中促成APOL1诱导的足细胞损伤。
Exp Mol Pathol. 2015 Jun;98(3):491-501. doi: 10.1016/j.yexmp.2015.03.020. Epub 2015 Mar 18.
2
APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.APOL1 风险变异通过损害溶酶体膜通透性增强足细胞坏死。
Am J Physiol Renal Physiol. 2014 Aug 1;307(3):F326-36. doi: 10.1152/ajprenal.00647.2013. Epub 2014 Jun 4.
3
Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.APOL1基因多态性和白细胞介素-1β预处理对HIV-1进入和存留于人类足细胞中的影响。
Retrovirology. 2016 Sep 6;13(1):63. doi: 10.1186/s12977-016-0296-3.
4
Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1.外显子4编码序列是载脂蛋白L1细胞毒性的主要决定因素。
Am J Physiol Cell Physiol. 2015 Jul 1;309(1):C22-37. doi: 10.1152/ajpcell.00384.2014. Epub 2015 Apr 29.
5
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.足细胞中人类APOL1风险变异体的转基因表达可诱发小鼠肾病。
Nat Med. 2017 Apr;23(4):429-438. doi: 10.1038/nm.4287. Epub 2017 Feb 20.
6
APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.APOL1-G0 可保护 HIV 相关肾病小鼠模型中的足细胞。
PLoS One. 2019 Oct 29;14(10):e0224408. doi: 10.1371/journal.pone.0224408. eCollection 2019.
7
APOL1 localization in normal kidney and nondiabetic kidney disease.APOL1 在正常肾脏和非糖尿病肾脏疾病中的定位。
J Am Soc Nephrol. 2011 Nov;22(11):2119-28. doi: 10.1681/ASN.2011010069. Epub 2011 Oct 13.
8
From man to fish: What can Zebrafish tell us about ApoL1 nephropathy?从人类到鱼类:斑马鱼能告诉我们关于载脂蛋白L1肾病的哪些信息?
Clin Nephrol. 2016;86 (2016)(13):114-118. doi: 10.5414/CNP86S116.
9
Disrupted apolipoprotein L1-miR193a axis dedifferentiates podocytes through autophagy blockade in an APOL1 risk milieu.载脂蛋白 L1- miR193a 轴的紊乱通过自噬阻断在 APOL1 风险环境中使足细胞去分化。
Am J Physiol Cell Physiol. 2019 Aug 1;317(2):C209-C225. doi: 10.1152/ajpcell.00538.2018. Epub 2019 May 22.
10
Effect of disease risk variants on gene product.疾病风险变异对基因产物的影响。
Biosci Rep. 2017 Apr 28;37(2). doi: 10.1042/BSR20160531. Print 2017 Apr 30.

引用本文的文献

1
A Cell Biologist's View on APOL1: What We Know and What We Still Need to Address.一位细胞生物学家对载脂蛋白L1(APOL1)的看法:我们所知道的以及仍需解决的问题。
Cells. 2025 Jun 24;14(13):960. doi: 10.3390/cells14130960.
2
A SNARE protective pool antagonizes APOL1 renal toxicity in Drosophila nephrocytes.一个SNARE保护池可拮抗果蝇肾细胞中APOL1的肾毒性。
Cell Biosci. 2023 Nov 4;13(1):199. doi: 10.1186/s13578-023-01147-8.
3
NEF-Induced HIV-Associated Nephropathy Through HCK/LYN Tyrosine Kinases.NEF 诱导的 HIV 相关肾病通过 HCK/LYN 酪氨酸激酶。
Am J Pathol. 2023 Jun;193(6):702-724. doi: 10.1016/j.ajpath.2023.02.006. Epub 2023 Mar 1.
4
variant-expressing endothelial cells exhibit autophagic dysfunction and mitochondrial stress.表达变体的内皮细胞表现出自噬功能障碍和线粒体应激。
Front Genet. 2022 Sep 27;13:769936. doi: 10.3389/fgene.2022.769936. eCollection 2022.
5
Endoplasmic reticulum-translocation is essential for APOL1 cellular toxicity.内质网转位对于载脂蛋白L1(APOL1)的细胞毒性至关重要。
iScience. 2021 Dec 31;25(1):103717. doi: 10.1016/j.isci.2021.103717. eCollection 2022 Jan 21.
6
Genetic Variants Are Associated With Increased Risk of Coronary Atherosclerotic Plaque Rupture in the Black Population.遗传变异与黑人人群中冠状动脉粥样硬化斑块破裂的风险增加相关。
Arterioscler Thromb Vasc Biol. 2021 Jul;41(7):2201-2214. doi: 10.1161/ATVBAHA.120.315788. Epub 2021 May 27.
7
APOL1 polymorphism modulates sphingolipid profile of human podocytes.APOL1 多态性调节人足细胞的神经鞘脂谱。
Glycoconj J. 2020 Dec;37(6):729-744. doi: 10.1007/s10719-020-09944-w. Epub 2020 Sep 11.
8
Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background.载脂蛋白 L1(APOL1)风险变异的毒性取决于单倍型背景。
Kidney Int. 2019 Dec;96(6):1303-1307. doi: 10.1016/j.kint.2019.07.010. Epub 2019 Aug 1.
9
APOL1 Kidney Risk Variants Induce Cell Death Mitochondrial Translocation and Opening of the Mitochondrial Permeability Transition Pore.APOL1 肾脏风险变异诱导细胞死亡、线粒体易位和线粒体通透性转换孔开放。
J Am Soc Nephrol. 2019 Dec;30(12):2355-2368. doi: 10.1681/ASN.2019020114. Epub 2019 Sep 26.
10
APOL1 and kidney cell function.APOL1 与肾脏细胞功能。
Am J Physiol Renal Physiol. 2019 Aug 1;317(2):F463-F477. doi: 10.1152/ajprenal.00233.2019. Epub 2019 Jun 26.

本文引用的文献

1
Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1.先天性免疫通路调节肾病基因载脂蛋白L1。
Kidney Int. 2015 Feb;87(2):332-42. doi: 10.1038/ki.2014.270. Epub 2014 Aug 6.
2
APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes.APOL1与2型糖尿病非裔美国人的肾病、动脉粥样硬化及全因死亡率的关联。
Kidney Int. 2015 Jan;87(1):176-81. doi: 10.1038/ki.2014.255. Epub 2014 Jul 23.
3
Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.在收缩压干预试验中,载脂蛋白L1基因变异与普遍存在的肾脏疾病相关,但与普遍存在的心血管疾病无关。
Kidney Int. 2015 Jan;87(1):169-75. doi: 10.1038/ki.2014.254. Epub 2014 Jul 16.
4
Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines.载脂蛋白L1(APOL1)蛋白和mRNA在人肾脏中的定位:非病变组织、原代细胞和永生化细胞系
J Am Soc Nephrol. 2015 Feb;26(2):339-48. doi: 10.1681/ASN.2013091017. Epub 2014 Jul 10.
5
APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.APOL1 风险变异通过损害溶酶体膜通透性增强足细胞坏死。
Am J Physiol Renal Physiol. 2014 Aug 1;307(3):F326-36. doi: 10.1152/ajprenal.00647.2013. Epub 2014 Jun 4.
6
Evolution of the primate trypanolytic factor APOL1.灵长类动物溶细胞因子 APOL1 的进化。
Proc Natl Acad Sci U S A. 2014 May 20;111(20):E2130-9. doi: 10.1073/pnas.1400699111. Epub 2014 May 7.
7
Glomerular disease: looking beyond pathology.肾小球疾病:超越病理学的观察。
Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1138-40. doi: 10.2215/CJN.01450214. Epub 2014 Apr 3.
8
HIV protein Nef causes dyslipidemia and formation of foam cells in mouse models of atherosclerosis.HIV 蛋白 Nef 导致动脉粥样硬化小鼠模型中的血脂异常和泡沫细胞形成。
FASEB J. 2014 Jul;28(7):2828-39. doi: 10.1096/fj.13-246876. Epub 2014 Mar 18.
9
Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.携带 APOL1 基因突变的个体心血管疾病负担增加。
Circ Res. 2014 Feb 28;114(5):845-50. doi: 10.1161/CIRCRESAHA.114.302347. Epub 2013 Dec 30.
10
Plasma apolipoprotein L1 levels do not correlate with CKD.血浆载脂蛋白 L1 水平与 CKD 不相关。
J Am Soc Nephrol. 2014 Mar;25(3):634-44. doi: 10.1681/ASN.2013070700. Epub 2013 Nov 14.